Transformation in Cancer Detection Through AI Technology
Experts suggest that artificial intelligence could profoundly change how cancer is detected and treated by American doctors.
AI is increasingly being integrated into the national healthcare system. Analysts noted that this technology might greatly enhance cancer detection, data analysis, and patient diagnosis.
“AI in cancer detection holds incredible potential,” shared Andy Jung, associate counsel at TechFreedom. “It’s essential to keep human doctors involved in the diagnostic process while we investigate AI’s effectiveness in actual medical environments and improve training to ensure physicians are comfortable utilizing these tools.”
In a randomized study conducted in 2024, researchers assessed diagnostic abilities across three groups: doctors relying on traditional methods, those using GPT-4, and an AI model operating independently. According to Jung, GPT-4 performed the best when paired with physicians, with its scores ranking just above that of AI alone, while doctors on their own typically scored the lowest. Intriguingly, even when doctors had the help of GPT-4, there were instances where AI incorrectly overruled the physician’s diagnosis despite offering the correct one itself.
GPT-4 is an advanced language model developed by OpenAI that can comprehend and generate human language through extensive textual data processing.
In October 2025, researchers from the University of Southern California reported the development of a new AI algorithm capable of automatically identifying a few cancer cells among millions of normal blood cells in roughly ten minutes.
Additionally, another AI model from the Mayo Clinic has shown the ability to detect pancreatic cancer through routine abdominal CT scans, potentially up to three years prior to clinical diagnosis. By 2026, it’s anticipated that around 67,530 people will be diagnosed with pancreatic cancer in the U.S., with approximately 52,740 expected to succumb to the disease, based on American Cancer Society estimates.
“Numerous studies have indicated that AI may excel at identifying lesions in CT scans and MRIs—maybe even mammograms. Our human limitations, especially distractions, can prevent us from spotting subtle findings that AI would catch,” said Jeffrey Singer, senior research scientist at the CATO Institute. He believes AI can provide substantial assistance, especially in screening imaging studies, citing existing evidence of its effectiveness.
Moreover, in clinical settings, AI can assist with analyzing blood test results and more. “AI systems have the capability to consider patterns and insights that a busy human doctor might overlook,” Singer added. “It’s just overwhelming for any one person to stay updated on every relevant study published daily, but these AIs can.”
Researchers at Washington University School of Medicine have also pioneered AI technology to analyze mammograms, aiming to enhance predictions of a woman’s five-year breast cancer risk.
AI could potentially optimize radiation doses, support surgical methods, and adapt treatment plans in real-time as necessary. The Cancer Research Institute mentioned that AI might also streamline the processes involved in the research and development of new cancer treatments.
However, there is a concern that relying on AI in healthcare could lead to patient injuries and additional medical issues due to system errors, as highlighted by the Brookings Institution.
A notable trend is that some Americans are increasingly seeking medical advice through AI. A recent study indicated that about 25% of individuals have utilized AI tools or chatbots for health-related inquiries.
The previous administration promoted the incorporation of AI in medical care. In December 2025, the Department of Health and Human Services announced a new AI strategy aimed at enhancing efficiency, stimulating innovation, improving patient outcomes, and ultimately contributing to the nation’s health.
